The Litigator of the Week crown goes to a Latham & Watkins global IP co-chair Michael Morin and partner David Frazier, who delivered a save worth billions to clients Janssen Biotech Inc. and Genmab A/S.

Janssen (which is part of Johnson & Johnson) and Genmab were sued for patent infringement by competitor MorphoSys AG, represented by Kirkland & Ellis. At issue: IP rights to blood cancer drug Darzalex, which Genmab invented and Janssen licensed and markets.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]